CN104316710B - 一种血清脂蛋白亚型精细亚组分微流控芯片分析系统 - Google Patents
一种血清脂蛋白亚型精细亚组分微流控芯片分析系统 Download PDFInfo
- Publication number
- CN104316710B CN104316710B CN201410590835.7A CN201410590835A CN104316710B CN 104316710 B CN104316710 B CN 104316710B CN 201410590835 A CN201410590835 A CN 201410590835A CN 104316710 B CN104316710 B CN 104316710B
- Authority
- CN
- China
- Prior art keywords
- arm
- transverse arm
- hypotype
- chip
- trailing arm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004895 Lipoproteins Human genes 0.000 title claims abstract description 24
- 108090001030 Lipoproteins Proteins 0.000 title claims abstract description 24
- 210000002966 serum Anatomy 0.000 title claims abstract description 17
- 238000001962 electrophoresis Methods 0.000 claims abstract description 26
- 239000002699 waste material Substances 0.000 claims abstract description 10
- 238000012360 testing method Methods 0.000 claims abstract description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract description 26
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract description 26
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 7
- 238000003745 diagnosis Methods 0.000 abstract description 6
- 238000011156 evaluation Methods 0.000 abstract description 4
- 238000013461 design Methods 0.000 abstract description 3
- 239000002245 particle Substances 0.000 description 12
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 208000010152 Huntington disease-like 3 Diseases 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000002032 lab-on-a-chip Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013499 data model Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002298 density-gradient ultracentrifugation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410590835.7A CN104316710B (zh) | 2014-10-29 | 2014-10-29 | 一种血清脂蛋白亚型精细亚组分微流控芯片分析系统 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410590835.7A CN104316710B (zh) | 2014-10-29 | 2014-10-29 | 一种血清脂蛋白亚型精细亚组分微流控芯片分析系统 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104316710A CN104316710A (zh) | 2015-01-28 |
CN104316710B true CN104316710B (zh) | 2016-05-04 |
Family
ID=52371963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410590835.7A Active CN104316710B (zh) | 2014-10-29 | 2014-10-29 | 一种血清脂蛋白亚型精细亚组分微流控芯片分析系统 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104316710B (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6120666A (en) * | 1996-09-26 | 2000-09-19 | Ut-Battelle, Llc | Microfabricated device and method for multiplexed electrokinetic focusing of fluid streams and a transport cytometry method using same |
EP1285259A1 (en) * | 2000-03-10 | 2003-02-26 | DNA Sciences, Inc. | Cross channel device for serial sample injection |
CN100397072C (zh) * | 2005-07-20 | 2008-06-25 | 中国科学院上海微系统与信息技术研究所 | 一种小型微流控芯片电泳检测系统和检测自动控制方法 |
CN103344631A (zh) * | 2013-07-15 | 2013-10-09 | 浙江省海洋水产研究所 | 非水电泳分离和过氧草酸酯类化学发光检测的微流控芯片 |
CN104297327B (zh) * | 2014-10-29 | 2017-01-18 | 广东国盛医学科技股份有限公司 | 一种采用微流控芯片分析血清脂蛋白亚型精细亚组分的方法 |
-
2014
- 2014-10-29 CN CN201410590835.7A patent/CN104316710B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104316710A (zh) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Andersen et al. | Validation of a fully automated robotic setup for preparation of whole blood samples for LC–MS toxicology analysis | |
Kim et al. | Microfluidic pipette tip for high-purity and high-throughput blood plasma separation from whole blood | |
Holcar et al. | Enrichment of plasma extracellular vesicles for reliable quantification of their size and concentration for biomarker discovery | |
CN104830986A (zh) | 一种检测胎儿基因信息的方法、装置和系统 | |
Lucien et al. | MIBlood‐EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research | |
EP2128607A1 (en) | Examination value predicting device using electrophoresis waveform, predicting method, and predicting program | |
Schroder et al. | Methylmalonic acid quantified in dried blood spots provides a precise, valid, and stable measure of functional vitamin B-12 status in healthy women | |
CN105092765A (zh) | 一种灵芝孢子粉原料有效成分的检测方法 | |
CN104297327B (zh) | 一种采用微流控芯片分析血清脂蛋白亚型精细亚组分的方法 | |
D’Urso et al. | Therapeutic drug monitoring of antiseizure medications using volumetric absorptive microsampling: where are we? | |
Lapić et al. | Ves-Matic CUBE 200: is modified Westergren method for erythrocyte sedimentation rate a valid alternative to the gold standard? | |
CN104034716A (zh) | 基于拉曼散射增强的纳米光纤探针的在体药物检测系统 | |
CN104316710B (zh) | 一种血清脂蛋白亚型精细亚组分微流控芯片分析系统 | |
Lima‐Oliveira et al. | The impact of fist clenching and its maintenance during venipuncture on routine hematology testing | |
Alauddin et al. | HbA2 levels in normal,-thalassaemia and haemoglobin E carriers by capillary electrophoresis | |
Wang et al. | Methods and advances in the design, testing and development of in vitro diagnostic instruments | |
WO2013188879A1 (en) | Measurement of serum lipoproteins | |
Oris et al. | Measurement of S100B protein: evaluation of a new prototype on a bioMérieux Vidas® 3 analyzer | |
CN105353047A (zh) | 骨质疏松血清代谢标记物的测定方法及应用 | |
CN105004833A (zh) | 一种治疗急性痛风性关节炎、痛风的中药制剂的检测方法 | |
Ahn et al. | Comparison of Improvacuter EDTA Tube with BD Vacutainer EDTA Tube for Routine Hematological Analysis: Clinical Significance of Differences, Stability Study, and Effects of K2 and K3 EDTA | |
Stephen et al. | Analytical comparison between microhematocrit and automated methods for packed cell volume (PCV) determination | |
CN114062209A (zh) | 血液分析仪 | |
Solé-Enrech et al. | Elimination of lipaemic interference by high-speed centrifugation | |
Arikan et al. | Comparison of the erythrocyte sedimentation rate measured by the Micro Test 1 Sedimentatıon Analyzer and the conventional Westergren method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170825 Address after: No. 11, Kaiyuan Avenue, science and Technology Development Zone, Guangzhou, Guangdong Province, No. fourth, building C1, Guangzhou science and technology enterprise accelerator Patentee after: Guangzhou Guosheng gene Mdt InfoTech Ltd Address before: The United States of California mountain view showers Lane No. 49 T409 unit Patentee before: Deng Xingfei |
|
CB03 | Change of inventor or designer information |
Inventor after: Deng Xingfei Inventor after: Zheng Hao Inventor before: Deng Xingfei |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201223 Address after: 510530 4th floor, building C1, No. 11, Kaiyuan Avenue, Science City, Guangzhou high tech Industrial Development Zone, Guangdong Province Patentee after: GUANGDONG ARDENT BIOMED TECHNOLOGY Co.,Ltd. Address before: 510000 4th floor, building C1, Guangzhou Science and technology enterprise accelerator, 11 Kaiyuan Avenue, Science City, Guangzhou high tech Industrial Development Zone, Guangdong Province Patentee before: Guangzhou Guosheng gene Mdt InfoTech Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A microfluidic chip analysis system for fine sub components of serum lipoprotein subtypes Effective date of registration: 20211214 Granted publication date: 20160504 Pledgee: Bank of China Limited by Share Ltd. Guangzhou Panyu branch Pledgor: GUANGDONG ARDENT BIOMED TECHNOLOGY CO.,LTD. Registration number: Y2021980014989 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |